Merck KGaA (OTCMKTS:MKGAF – Get Free Report)’s stock price shot up 6.4% during trading on Monday . The stock traded as high as $145.2050 and last traded at $145.2050. 90 shares were traded during mid-day trading, a decline of 90% from the average session volume of 878 shares. The stock had previously closed at $136.50.
Merck KGaA Price Performance
The business’s 50-day simple moving average is $135.21 and its two-hundred day simple moving average is $131.99. The stock has a market cap of $17.72 billion, a price-to-earnings ratio of 20.93 and a beta of 0.96. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.31 and a quick ratio of 0.84.
About Merck KGaA
Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company's Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector.
Featured Stories
- Five stocks we like better than Merck KGaA
- What is diluted earnings per share (Diluted EPS)?
- 5 Tech Stocks Insiders Are Selling (But Smart Investors Are Loading Up)
- Should You Invest in Penny Stocks?
- Why FuelCell Energy Stock Is Soaring After a Government Deal
- What Do S&P 500 Stocks Tell Investors About the Market?
- SoftBankâs Next AI Move? DigitalBridge Rockets 46% on Takeover Buzz
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
-logo-1200x675.png?v=20240604134456&h=45&w=95&zc=2){kind=logo}
